Faculty of Medicine;
University of Porto;
4200-319 Porto;
Portugal;
Molecular Oncology Group;
Research Center;
Portuguese Oncology Institute;
4200-072 Porto;
Portugal;
Department of Medical Oncology;
Portuguese Oncology Institute;
4200-072 Porto;
Portugal;
The Royal Marsden NHS Foundation Trust;
London;
SW3 6JJ;
United Kingdom;
Colorectal; cancer; Bevacizumab; Cetuximab; Aflibercept; FOLFOX; FOLFIRI;